USP10/GSK3B-mediated inhibition of PTEN drives resistance to PI3K inhibitors in breast cancer

Journal:

Journal of Clinical Investigation

Published:

2025-09-23

DOI:

10.1172/jci180927

Affiliations:

22

Authors:

37

Go to article

Institutions	Authors	Share
Curtin University, Australia	9.000000	0.24
National University of Singapore (NUS), Singapore	3.666667	0.10
University Hospital of Würzburg (UKW), JMU, Germany	3.500000	0.09
Vall d'Hebron Research Institute (VHIR), HUVH ICS, Spain	3.000000	0.08
Walter and Eliza Hall Institute of Medical Research (WEHI), Australia	3.000000	0.08
Harry Perkins Institute of Medical Research (HPIMR), Australia	2.000000	0.05
University of Waterloo, Canada	2.000000	0.05
Helmholtz Zentrum München - German Research Center for Environmental Health (HMGU), Germany	1.333333	0.04
The German Center for Lung Research (DZL), Germany	1.333333	0.04
Massachusetts General Hospital Cancer Center, United States of America (USA)	1.000000	0.03
Ben-Gurion University of the Negev (BGU), Israel	1.000000	0.03
The University of Melbourne (UniMelb), Australia	1.000000	0.03
Western Diagnostic Pathology, Australia	1.000000	0.03
Oklahoma State University, United States of America (USA)	1.000000	0.03
The University of Texas MD Anderson Cancer Center, United States of America (USA)	1.000000	0.03
Imperial College London (ICL), United Kingdom (UK)	1.000000	0.03
University of Würzburg (JMU), Germany	0.500000	0.01
Ludwig Maximilians University of Munich (LMU), Germany	0.333333	0.01
Genome Institute of Singapore (GIS), A*STAR, Singapore	0.333333	0.01

Interested in Oncology and Carcinogenesis?